Form 4 for SMMT Summit Therapeutics Inc.
Accepted 2025-10-23 00:00:00 ET · period of report 2025-10-21 · accession 0001569769-25-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-23 | 2025-10-21 | SMMT | Soni Manmeet Singh | COO, CFO, Dir | A - Grant | $18.74 | +53.4K | 3.07M | +2% | +$1000.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-21 | A | A | 53,361 | $18.74 | 3,073,603 | D | — | — | (F1) Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of October 21, 2025, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person and certain other parties at a purchase price of $18.74 per share. The transaction is anticipated to close on or about October 23, 2025. |